I bought more today and will continue to do so until I hear if/when they are taking analogs to the clinic. I think Humalog goes off patent first out of the big 3. I'm bettting Lily will want to give it a try in the clinic to protect their patent imho.
you will absolutely hear in November that they are taking an analog version into the clinic. It will either be with Lilly or Sanofi as a partner or by using API from a foreign source. Either way, Biodel is taking an analog version into the clinic fairly soon. I agree with you that it is most likely Lilly...but for slightly different reasons.